Biosimilar Utilization and Inventory Management

Video content above is prompted by the following:

• How has the introduction of biosimilars affected the biologic landscape at specialty pharmacies, including the disease states treated and trends in utilization?
• What strategies, including the “just in time” inventory model, can specialty pharmacies employ to effectively manage their high-cost biologic and biosimilar inventory given the challenges of limited shelf space?